2025³â 01¿ù 12ÀÏ ÀÏ¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > ´º½ºÁö´åÄÄ > Science & Technology

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýÈ°

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óÇ°

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
- - - - - - -
 

LYCRA Makes Significant Progress on Decarbonization Plan With SBTi Approving Near-Term Emissions Reduction Targets

´º½ºÀÏÀÚ: 2024-08-09

WILMINGTON, DEL. -- The LYCRA Company, a global leader in developing innovative and sustainable fiber and technology solutions for the apparel and personal care industries, has announced that the Science Based Targets initiative (SBTi) has approved its near-term science-based emissions reduction targets.

The SBTi has validated that the company’s Scope 1 and 2 greenhouse gas (GHG) target ambitions align with a 1.5-degree Celsius trajectory, as recommended by the Paris Agreement. The LYCRA Company has committed to reduce absolute Scope 1 and 2 GHG emissions by 50 percent by 2030 from a 2021 base year. In addition, the company will reduce absolute Scope 3 GHG emissions from purchased goods and services by 25 percent within the same timeframe.

“This has been a two-year effort to identify and select the best options for our business and create a road map for carbon reduction,” said Robert Johnston, executive vice president of operations at The LYCRA Company. “That plan includes changes to our processes, products, and key ingredients, as well as securing buy-in from internal and external stakeholders.”

To reduce Scope 1 emissions, The LYCRA Company is moving to lower-impact energy sources at its production sites. Work is already underway to convert its Maydown, Northern Ireland, site to cleaner fuel sources, with project completion anticipated by the first quarter of 2025.

By converting purchased electricity to renewable sources through Energy Attribute Certificates, The LYCRA Company is also reducing its Scope 2 emissions. This has been completed at production sites in Foshan, China, and Maydown, Northern Ireland. Two additional sites are being converted over the next two years.

The LYCRA Company also works with ingredient suppliers to convert to lower-impact inputs to reduce its Scope 3 emissions. An example is the company’s collaboration with Qore® to use its brand QIRA® to develop and commercialize bio-derived LYCRA® fiber at scale. Over the next several years, nearly 30 percent of the company’s current spandex capacity will be converted to bio-derived LYCRA® fiber.

“We are committed to making positive change in our industry and have set ambitious emission targets because we believe it’s essential for business success, but more importantly, it’s the right thing to do,” said Gary Smith, The LYCRA Company’s CEO. “By making these changes, we can help reduce not only our emissions but those of our customers as well.”



 Àüü´º½º¸ñ·ÏÀ¸·Î

IntelliVIX Unveils Next-Generation Generative AI Monitoring Platform ¡®Gen AMS¡¯ at CES 2025
Driving HVAC Innovation for a Smarter, More Efficient Future
Parse Biosciences Quadruples Sample Multiplexing Abilities for Evercode WT Mega Kits
Autel Energy at CES 2025: Unveiling Strategic Solutions for Intelligent EV Infrastructure
Laserfiche Recognized as a Leader in 2024 Gartner¢ç Magic Quadrant¢â for Document Management
Lenovo¢â at CES 2025: Pioneering the Future with AI-Powered Innovation for Business, Gaming, and Creative Users
Neural Concept and OPmobility Announce Partnership and Demonstrate New AI-Driven Designs

 

VeriSilicon Unveils Next-Generation High-Performance Vitality Architec...
Biocytogen Announces Adcendo ApS Exercises Antibody Option to Accelera...
Takeda Announces Approval of HYQVIA¢ç 10% S.C. (Subcutaneous) Injectio...
ROBOROBO Showcases Cutting-Edge AI Robot Solutions as an Official Spon...
Advancing Quantum Technology in Japan: AIST and IQM Join Forces
ClinChoice Extends 13-Year Medidata Partnership with the Addition of C...
Novotech Releases Report on Global Parkinson¡¯s Disease Clinical Trial...

 


°øÁö»çÇ×
´º½ºÁö ÇÑÀÚÇ¥±â 'ãæÚ¤ó¢'
´º½º±×·ì Á¤º¸ ¹Ìµð¾î ºÎ¹® »óÇ¥µî·Ï
¾ËÇÁ·Ò °è¿­ »óÇ¥, »óÇ¥µî·Ï ¿Ï·á
¾Ë¶ã°Ç¼³, »óÇ¥µî·Ï ¿Ï·á
Á¸Â÷´åÄÄ, ±Û²Ã º¯°æ »óÇ¥µî·Ï ¿Ï·á

 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æħ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇÑ°è¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, Æѽº 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..